Fast Facts: Multiple Myeloma and Plasma Cell Dyscrasias
Our understanding of multiple myeloma (MM) is growing at a formidable pace, particularly in terms of risk factors and potential drug targets. Minimal residual disease (MRD) negativity is set to become the new benchmark in treatment, and cytogenetic analysis is now paving the way for personalized the...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Livre numérique |
| اللغة: | Anglais |
| منشور في: |
Basel :
S. Karger
2017.
Basel : |
| الطبعة: | 2nd edition. |
| الوصول للمادة أونلاين: | https://www.karger.com/Book/Home/277600 Accès Université d'Orléans et IFPM |
| ملاحظة: |
Karger Fast Facts |
| Autres localisations: | Voir dans le Sudoc |
| Edition sous un autre format: | • Fast Facts: Multiple Myeloma and Plasma Cell Dyscrasias, 9781910797334 |